Announced key new appointments to its executive leadership team. This strategic move reflects Sernova's ...
Announces today that David Paterson Ph.D. will join Sernova’s Board of Directors effective immediately. ...
Announced the presentation of new positive interim data from the ongoing Phase I/II clinical trial evaluating ...
Has closed its non-brokered, private placement in the amount over $5.2 million, which includes over-subscriptions ...
Today announced a short oral presentation at the upcoming European Association for the Study of Diabetes ...
Announces developments in its Phase I/II clinical trial investigating a novel treatment for Type 1 Diabetes ...
/CNW/ - Sernova Corp. ("Sernova" or the "Company") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH) is pleased to announce that it has filed a preliminary short form...
Monday U.S. Featured Earnings Nucor Corporation (NYSE:NUE) (Q4) EPS of $2.83, compared ...
Announced the U.S. Food and Drug Administration (FDA) has granted both Orphan Drug Designation (ODD) ...
Announced an update on its conformal coating immune protection technology program, that is used in combination ...